AI assistant
Sending…
BOSTON SCIENTIFIC CORP — Director's Dealing 2020
Jan 6, 2020
29821_dirs_2020-01-06_1233f6ca-d061-458f-844d-d09fd32dc7b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-01-03
Reporting Person: Ballinger Kevin J. (EVP & Pres, Interven Cardio)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-03 | Common Stock | S | 11036.0000 | $44.5200 | Disposed | 80057.0000 | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
More from BOSTON SCIENTIFIC CORP
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 18
Capital/Financing Update
2026
May 18
Share Issue/Capital Change
2026
May 8
Major Shareholding Notification
2026
May 6
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Interim / Quarterly Report
2026
May 1
Major Shareholding Notification
2026
Apr 29
Earnings Release
2026
Apr 22
Regulatory Filings
2026
Apr 2